{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:15:15Z","timestamp":1792757715674,"version":"4.5.0"},"reference-count":42,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2010,12,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>There is a long-standing controversy in the literature as to whether sickle-cell trait (SCT) should be viewed as a benign carrier state or as an intermediate disease phenotype. Because SCT is routinely detected by neonatal screening for sickle-cell disease, it becomes imperative that consensus on this issue be achieved in order to provide the best medical advice to affected individuals. The issue of selective screening in the post-neonatal period was thrust into the limelight recently by the National Collegiate Athletic Association's recommendation that its member colleges and universities test student-athletes to confirm their carrier status if not already known. The stated goal of this recommendation was to prevent exercise-related sudden death in athletes with SCT. We review some of the reported complications of SCT for which new information has emerged, focusing particularly on venous thromboembolism and renal manifestations.<\/jats:p>","DOI":"10.1182\/asheducation-2010.1.418","type":"journal-article","created":{"date-parts":[[2011,1,16]],"date-time":"2011-01-16T19:08:48Z","timestamp":1295204928000},"page":"418-422","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":94,"title":["Sickle-Cell Trait: Novel Clinical Significance"],"prefix":"10.1182","volume":"2010","author":[{"given":"Nigel S.","family":"Key","sequence":"first","affiliation":[{"name":"Division of Hematology\/Oncology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vimal K.","family":"Derebail","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, UNC Kidney Center, University of North Carolina School of Medicine, Chapel Hill, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"18","key":"2019111708455607900_B1","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM197905033001801","article-title":"Clinical implications of sickle-cell trait and glucose-6-phosphate dehydrogenase deficiency in hospitalized black male patients","volume":"300","author":"Heller","year":"1979","journal-title":"N Engl J Med"},{"issue":"5","key":"2019111708455607900_B2","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1182\/blood.V48.5.629.bloodjournal485629","article-title":"Abnormal hemoglobins in a quarter million people","volume":"48","author":"Schneider","year":"1976","journal-title":"Blood"},{"issue":"4857","key":"2019111708455607900_B3","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1136\/bmj.1.4857.290","article-title":"Protection afforded by sickle-cell trait against subtertian malareal infection","volume":"1","author":"Allison","year":"1954","journal-title":"Br Med J"},{"issue":"1","key":"2019111708455607900_B4","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1086\/430744","article-title":"Sickle cell trait and the risk of Plasmodium falciparum malaria and other childhood diseases","volume":"192","author":"Williams","year":"2005","journal-title":"J Infect Dis"},{"issue":"8","key":"2019111708455607900_B5","first-page":"751","article-title":"Sickle cell trait: an update","volume":"74","author":"Johnson","year":"1982","journal-title":"J Natl Med Assoc"},{"issue":"4058","key":"2019111708455607900_B6","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1126\/science.178.4058.283","article-title":"Sickle cell anemia: national program raises problems as well as hopes","volume":"178","author":"Culliton","year":"1972","journal-title":"Science"},{"issue":"6","key":"2019111708455607900_B7","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.amjmed.2008.12.020","article-title":"Complications associated with sickle cell trait: a brief narrative review","volume":"122","author":"Tsaras","year":"2009","journal-title":"Am J Med"},{"issue":"11","key":"2019111708455607900_B8","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1182\/blood-2003-11-3758","article-title":"Survival of children with sickle cell disease","volume":"103","author":"Quinn","year":"2004","journal-title":"Blood"},{"issue":"1","key":"2019111708455607900_B9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/ajmg.c.30160","article-title":"Communication of positive newborn screening results for sickle cell disease and sickle cell trait: variation across states","volume":"148C","author":"Kavanagh","year":"2008","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"4","key":"2019111708455607900_B10","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1432-2277.2007.00611.x","article-title":"Screening for sickle trait among potential live kidney donors: policies and practices in US transplant centers","volume":"21","author":"Reese","year":"2008","journal-title":"Transpl Int"},{"issue":"13","key":"2019111708455607900_B11","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJM198709243171301","article-title":"Sickle-cell trait as a risk factor for sudden death in physical training","volume":"317","author":"Kark","year":"1987","journal-title":"N Engl J Med"},{"issue":"3","key":"2019111708455607900_B12","first-page":"181","article-title":"Exercise and hemoglobin S","volume":"31","author":"Kark","year":"1994","journal-title":"Semin Hematol"},{"issue":"11","key":"2019111708455607900_B13","doi-asserted-by":"crossref","first-page":"931","DOI":"10.2165\/00007256-200838110-00004","article-title":"Physiological responses of sickle cell trait carriers during exercise","volume":"38","author":"Connes","year":"2008","journal-title":"Sports Med"},{"issue":"2","key":"2019111708455607900_B14","doi-asserted-by":"crossref","first-page":"H375","DOI":"10.1152\/ajpheart.00812.2009","article-title":"Remodeling of skeletal muscle microvasculature in sickle cell trait and alpha-thalassemia","volume":"298","author":"Vincent","year":"2010","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2019111708455607900_B15","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1182\/asheducation-2007.1.91","article-title":"Hypercoagulability in sickle cell disease: new approaches to an old problem","author":"Ataga","year":"2007","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"5","key":"2019111708455607900_B16","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.ajog.2005.11.008","article-title":"Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality","volume":"194","author":"James","year":"2006","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"2019111708455607900_B17","first-page":"S125","article-title":"Impact of sickle hemoglobinopathies on pregnancy-related venous thromboembolism. i","volume":"199","author":"Tita","year":"2009"},{"issue":"10","key":"2019111708455607900_B18","doi-asserted-by":"crossref","first-page":"897.e7","DOI":"10.1016\/j.amjmed.2006.08.015","article-title":"Deep venous thrombosis and pulmonary embolism in hospitalized patients with sickle cell disease","volume":"119","author":"Stein","year":"2006","journal-title":"Am J Med"},{"issue":"1","key":"2019111708455607900_B19","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1046\/j.1538-7836.2003.00031.x","article-title":"The epidemiology of venous thromboembolism in Caucasians and African-Americans: the GATE Study","volume":"1","author":"Dowling","year":"2003","journal-title":"J Thromb Haemost"},{"issue":"3","key":"2019111708455607900_B20","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1182\/blood-2006-11-057604","article-title":"Sickle cell trait and the risk of venous thromboembolism among blacks","volume":"110","author":"Austin","year":"2007","journal-title":"Blood"},{"issue":"6","key":"2019111708455607900_B21","doi-asserted-by":"crossref","first-page":"620.e1","DOI":"10.1016\/j.ajog.2009.01.038","article-title":"Hormonal contraception, sickle cell trait, and risk for venous thromboembolism among African American women","volume":"200","author":"Austin","year":"2009","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"2019111708455607900_B22","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1182\/blood-2002-05-1416","article-title":"Fibrin fragment D-dimer and the risk of future venous thrombosis","volume":"101","author":"Cushman","year":"2003","journal-title":"Blood"},{"issue":"2","key":"2019111708455607900_B23","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/ajh.10021","article-title":"Coagulation changes in individuals with sickle cell trait","volume":"69","author":"Westerman","year":"2002","journal-title":"Am J Hematol"},{"issue":"5","key":"2019111708455607900_B24","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0002-9343(55)80022-8","article-title":"Gross hematuria in sickle cell trait and sickle cell hemoglobin-C disease","volume":"19","author":"Chapman","year":"1955","journal-title":"Am J Med"},{"issue":"6","key":"2019111708455607900_B25","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/0002-9343(78)90458-8","article-title":"The morbidity of sickle cell trait: a review of the literature","volume":"64","author":"Sears","year":"1978","journal-title":"Am J Med"},{"issue":"7","key":"2019111708455607900_B26","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/sj.ki.5002060","article-title":"Sickle cell trait and gross hematuria","volume":"71","author":"Kiryluk","year":"2007","journal-title":"Kidney Int"},{"issue":"7644","key":"2019111708455607900_B27","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0140-6736(70)90836-6","article-title":"Nature of concentrating defect in sickle-cell nephropathy. Microradioangiographic studies","volume":"1","author":"Statius van Eps","year":"1970","journal-title":"Lancet"},{"issue":"3","key":"2019111708455607900_B28","first-page":"300","article-title":"Sickle cell trait and sudden death\u2013bringing it home","volume":"99","author":"Mitchell","year":"2007","journal-title":"J Natl Med Assoc"},{"issue":"5","key":"2019111708455607900_B29","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1056\/NEJM198202043060504","article-title":"Concurrent sickle-cell anemia and alpha-thalassemia: effect on severity of anemia","volume":"306","author":"Embury","year":"1982","journal-title":"N Engl J Med"},{"issue":"1","key":"2019111708455607900_B30","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/ajh.2830220108","article-title":"Influence of HbS levels upon the hematological and clinical characteristics of sickle cell trait","volume":"22","author":"Kennedy","year":"1986","journal-title":"Am J Hematol"},{"issue":"6","key":"2019111708455607900_B31","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1172\/JCI115521","article-title":"Effects of alpha-thalassemia and sickle polymerization tendency on the urine-concentrating defect of individuals with sickle cell trait","volume":"88","author":"Gupta","year":"1991","journal-title":"J Clin Invest"},{"issue":"1","key":"2019111708455607900_B32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000478-199501000-00001","article-title":"Renal medullary carcinoma. The seventh sickle cell nephropathy","volume":"19","author":"Davis","year":"1995","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"2019111708455607900_B33","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.5858\/2003-127-e135-RMCARO","article-title":"Renal medullary carcinoma: a report of 2 cases and review of the literature","volume":"127","author":"Dimashkieh","year":"2003","journal-title":"Arch Pathol Lab Med"},{"issue":"9","key":"2019111708455607900_B34","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1681\/ASN.V491670","article-title":"Autosomal dominant polycystic kidney disease in blacks: clinical course and effects of sickle-cell hemoglobin","volume":"4","author":"Yium","year":"1994","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"2019111708455607900_B35","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ejim.2004.06.003","article-title":"Sickle cell trait and gender influence type 2 diabetic complications in African patients","volume":"15","author":"Ajayi","year":"2004","journal-title":"Eur J Intern Med"},{"issue":"10","key":"2019111708455607900_B36","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1590\/S0100-879X1998001000004","article-title":"Renal dysfunction in patients with sickle cell anemia or sickle cell trait","volume":"31","author":"Sesso","year":"1998","journal-title":"Braz J Med Biol Res"},{"issue":"5","key":"2019111708455607900_B37","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1464-5491.2004.1134.x","article-title":"Albuminuria in Afro-Caribbeans with Type 2 diabetes mellitus: is the sickle cell trait a risk factor?","volume":"21","author":"Oli","year":"2004","journal-title":"Diabet Med"},{"issue":"3","key":"2019111708455607900_B38","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1681\/ASN.2009070705","article-title":"High prevalence of sickle cell trait in african americans with ESRD","volume":"21","author":"Derebail","year":"2010","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"2019111708455607900_B39","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1681\/ASN.2010010070","article-title":"Time to recognize an overlooked trait","volume":"21","author":"Cavanaugh","year":"2010","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"2019111708455607900_B40","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.2215\/CJN.08841209","article-title":"Sickle cell trait and development of microvascular complications in diabetes mellitus","volume":"5","author":"Bleyer","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"2019111708455607900_B41","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1053\/j.ajkd.2008.07.026","article-title":"The association of race with erythropoietin dose in patients on long-term hemodialysis","volume":"52","author":"Lacson","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"2019111708455607900_B42","article-title":"Variant hemoglobin phenotypes and erythropoietin-resistance in African-American hemodialysis patients","author":"Derebail"}],"container-title":["Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2010\/1\/418\/1492219\/bep00110000418.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2010\/1\/418\/1492219\/bep00110000418.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T13:47:24Z","timestamp":1637156844000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/hematology\/article\/2010\/1\/418\/95877\/SickleCell-Trait-Novel-Clinical-Significance"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,4]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12,4]]}},"URL":"https:\/\/doi.org\/10.1182\/asheducation-2010.1.418","relation":{},"ISSN":["1520-4391","1520-4383"],"issn-type":[{"value":"1520-4391","type":"print"},{"value":"1520-4383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,4]]}}}